Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2012 (2012), Article ID 758181, 12 pages
http://dx.doi.org/10.1155/2012/758181
Review Article

The Role of Purinergic Receptors in Cancer-Induced Bone Pain

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark

Received 9 April 2012; Accepted 22 August 2012

Academic Editor: Niklas Rye Jørgensen

Copyright © 2012 Sarah Falk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Delaney, S. M. Fleetwood-Walker, L. A. Colvin, and M. Fallon, “Translational medicine: cancer pain mechanisms and management,” British Journal of Anaesthesia, vol. 101, no. 1, pp. 87–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Urch, “The pathophysiology of cancer-induced bone pain: Current understanding,” Palliative Medicine, vol. 18, no. 4, pp. 267–274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. H. S. Smith, “Painful osseous metastases,” Pain Physician, vol. 14, no. 4, pp. E373–E405, 2011. View at Google Scholar · View at Scopus
  4. S. Mercadante, “Malignant bone pain: pathophysiology and treatment,” Pain, vol. 69, no. 1-2, pp. 1–18, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Mercadante, “Managing breakthrough pain,” Current Pain and Headache Reports, vol. 15, no. 4, pp. 244–249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. G. Lawlor and E. Bruera, “Side-effects of opioids in chronic pain treatment,” Current Opinion in Anaesthesiology, vol. 11, no. 5, pp. 539–545, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Honore, S. D. Rogers, M. J. Schwei et al., “Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons,” Neuroscience, vol. 98, no. 3, pp. 585–598, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Peters, J. R. Ghilardi, C. P. Keyser et al., “Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain,” Experimental Neurology, vol. 193, no. 1, pp. 85–100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Schwei, P. Honore, S. D. Rogers et al., “Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain,” Journal of Neuroscience, vol. 19, no. 24, pp. 10886–10897, 1999. View at Google Scholar · View at Scopus
  10. C. Pacharinsak and A. Beitz, “Animal models of cancer pain,” Comparative Medicine, vol. 58, no. 3, pp. 220–233, 2008. View at Google Scholar · View at Scopus
  11. M. A. Sevcik, J. R. Ghilardi, C. M. Peters et al., “Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization,” Pain, vol. 115, no. 1-2, pp. 128–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Geis, M. Graulich, A. Wissmann et al., “Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain,” Neuroscience, vol. 169, no. 1, pp. 463–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Sevcik, J. R. Ghilardi, K. G. Halvorson, T. H. Lindsay, K. Kubota, and P. W. Mantyh, “Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model,” Journal of Pain, vol. 6, no. 11, pp. 771–775, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. C. Sabino, J. R. Ghilardi, J. L. M. Jongen et al., “Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2,” Cancer Research, vol. 62, no. 24, pp. 7343–7349, 2002. View at Google Scholar · View at Scopus
  15. H. O. J. Collier, G. W. L. James, and C. Schneider, “Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5′-triphosphate,” Nature, vol. 212, no. 5060, pp. 411–412, 1966. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Burnstock, “Purinergic receptors and pain,” Current Pharmaceutical Design, vol. 15, no. 15, pp. 1717–1735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Burnstock, “A unifying purinergic hypothesis for the initiation of pain,” The Lancet, vol. 347, no. 9015, pp. 1604–1605, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Tsuda, H. Tozaki-Saitoh, and K. Inoue, “Pain and purinergic signaling,” Brain Research Reviews, vol. 63, no. 1-2, pp. 222–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Vial, J. A. Roberts, and R. J. Evans, “Molecular properties of ATP-gated P2X receptor ion channels,” Trends in Pharmacological Sciences, vol. 25, no. 9, pp. 487–493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Hattori and E. Gouaux, “Molecular mechanism of ATP binding and ion channel activation in P2X receptors,” Nature, vol. 485, pp. 207–212, 2012. View at Publisher · View at Google Scholar
  21. T. Kawate, J. C. Michel, W. T. Birdsong, and E. Gouaux, “Crystal structure of the ATP-gated P2X4 ion channel in the closed state,” Nature, vol. 460, no. 7255, pp. 592–598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. E. Browne, L. H. Jiang, and R. A. North, “New structure enlivens interest in P2X receptors,” Trends in Pharmacological Sciences, vol. 31, no. 5, pp. 229–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. North, “Molecular physiology of P2X receptors,” Physiological Reviews, vol. 82, no. 4, pp. 1013–1067, 2002. View at Google Scholar · View at Scopus
  24. F. Rassendren, G. N. Buell, C. Virginio, G. Collo, R. A. North, and A. Surprenant, “The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA,” The Journal of Biological Chemistry, vol. 272, no. 9, pp. 5482–5486, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Compan, L. Ulmann, O. Stelmashenko, J. Chemin, S. Chaumont, and F. Rassendren, “P2X2 and P2X5 subunits define a new heteromeric receptor with P2X7-Like properties,” The Journal of Neuroscience, vol. 32, no. 12, pp. 4284–4296, 2012. View at Google Scholar
  26. L. P. Bernier, A. R. Ase, E. Boué-Grabot, and P. Séguéla, “P2X4 receptor channels form large noncytolytic pores in resting and activated microglia,” Glia, vol. 60, no. 5, pp. 728–737, 2012. View at Publisher · View at Google Scholar
  27. G. Burnstock, “Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future,” Bioessays, vol. 34, no. 3, pp. 218–225, 2012. View at Publisher · View at Google Scholar
  28. R. A. Felix, S. Martin, S. Pinion, and D. J. Crawford, “Development of a comprehensive set of P2 receptor pharmacological research compounds,” Purinergic Signalling, vol. 8, supplement 1, pp. 101–112, 2012. View at Google Scholar
  29. G. Lambrecht, T. Friebe, U. Grimm et al., “PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses,” European Journal of Pharmacology, vol. 217, no. 2-3, pp. 217–219, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Wirkner, B. Sperlagh, and P. Illes, “P2X3 receptor involvement in pain states,” Molecular Neurobiology, vol. 36, no. 2, pp. 165–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Julius and A. I. Basbaum, “Molecular mechanisms of nociception,” Nature, vol. 413, no. 6852, pp. 203–210, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Djouhri and S. N. Lawson, “Aβ-fiber nociceptive primary afferent neurons: a review of incidence and properties in relation to other afferent a-fiber neurons in mammals,” Brain Research Reviews, vol. 46, no. 2, pp. 131–145, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. T. P. Doubell, R. J. Mannion, and C. J. Woolf, “The dorsal horn: State-dependent sensory processing, plasticity and the generation of pain,” in Textbook of Pain, P. D. Wall and R. Melzack, Eds., 4th edition, 1999. View at Google Scholar
  34. L. Vulchanova, M. S. Riedl, S. J. Shuster et al., “Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals,” Neuropharmacology, vol. 36, no. 9, pp. 1229–1242, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. P. M. Dunn, Y. Zhong, and G. Burnstock, “P2X receptors in peripheral neurons,” Progress in Neurobiology, vol. 65, no. 2, pp. 107–134, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. A. P. Ford, “In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization,” Purinergic Signal, vol. 8, supplement 1, pp. 3–26, 2012. View at Publisher · View at Google Scholar
  37. E. J. Bradbury, G. Burnstock, and S. B. McMahon, “The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor,” Molecular and Cellular Neurosciences, vol. 12, no. 4-5, pp. 256–268, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Vulchanova, M. S. Riedl, S. J. Shuster et al., “P2X3 is expressed by DRG neurons that terminate in inner lamina II,” European Journal of Neuroscience, vol. 10, no. 11, pp. 3470–3478, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. S. D. Novakovic, L. C. Kassotakis, I. B. Oglesby et al., “Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury,” Pain, vol. 80, no. 1-2, pp. 273–282, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Y. Xu and L. Y. M. Huang, “Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons,” Journal of Neuroscience, vol. 22, no. 1, pp. 93–102, 2002. View at Google Scholar · View at Scopus
  41. L. S. Gilchrist, D. M. Cain, C. Harding-Rose et al., “Re-organization of P2X3 receptor localization on epidermal nerve fibers in a murine model of cancer pain,” Brain Research, vol. 1044, no. 2, pp. 197–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Nagamine, N. Ozaki, M. Shinoda et al., “Mechanical allodynia and thermal hyperalgesia induced by experimental squamous cell carcinoma of the lower gingiva in rats,” Journal of Pain, vol. 7, no. 9, pp. 659–670, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. Xiang, X. Bo, and G. Burnstock, “Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia,” Neuroscience Letters, vol. 256, no. 2, pp. 105–108, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. J. A. Barden and M. R. Bennett, “Distribution of P2X purinoceptor clusters on individual rat dorsal root ganglion cells,” Neuroscience Letters, vol. 287, no. 3, pp. 183–186, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Z. Ruan and G. Burnstock, “Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat,” Histochemistry and Cell Biology, vol. 120, no. 5, pp. 415–426, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Aoyama, Y. Okada, S. Yokota et al., “Spatiotemporal and anatomical analyses of P2X receptor-mediated neuronal and glial processing of sensory signals in the rat dorsal horn,” Pain, vol. 152, no. 9, pp. 2085–2097, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Kanjhan, G. D. Housley, L. D. Burton et al., “Distribution of the P2X2 receptor subunit of the ATP-gated ion channels in the rat central nervous system,” Journal of Comparative Neurology, vol. 407, no. 1, pp. 11–32, 1999. View at Google Scholar · View at Scopus
  48. M. Tsuda, Y. Shigemoto-Mogami, S. Koizumi et al., “P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury,” Nature, vol. 424, no. 6950, pp. 778–783, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. Q. J. Gong, Y. Y. Li, W. J. Xin et al., “ATP induces long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn: the roles of P2X4 receptors and p38 MAPK in microglia,” Glia, vol. 57, no. 6, pp. 583–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Duan, C. M. Anderson, E. C. Keung, Y. Chen, Y. Chen, and R. A. Swanson, “P2X7 receptor-mediated release of excitatory amino acids from astrocytes,” Journal of Neuroscience, vol. 23, no. 4, pp. 1320–1328, 2003. View at Google Scholar · View at Scopus
  51. M. Kukley , J. A. Barden, C. Steinhäuser, and R. Jabs, “Distribution of P2x receptors on astrocytes in juvenile rat hippocampus,” Glia, vol. 36, no. 1, pp. 11–21, 2001. View at Google Scholar
  52. W. Panenka, H. Jijon, L. M. Herx et al., “P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase,” Journal of Neuroscience, vol. 21, no. 18, pp. 7135–7142, 2001. View at Google Scholar · View at Scopus
  53. S. O. Suadicani, C. F. Brosnan, and E. Scemes, “P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling,” Journal of Neuroscience, vol. 26, no. 5, pp. 1378–1385, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. A. K. Clark, A. A. Staniland, F. Marchand, T. K. Y. Kaan, S. B. McMahon, and M. Malcangio, “P2X7-dependent release of interleukin-1β and nociception in the spinal cord following lipopolysaccharide,” Journal of Neuroscience, vol. 30, no. 2, pp. 573–582, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. X. Chu, Y. Zhang, Y. Q. Zhang, and Z. Q. Zhao, “Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses,” Brain, Behavior, and Immunity, vol. 24, no. 7, pp. 1176–1189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. D. B. Mach, S. D. Rogers, M. C. Sabino et al., “Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur,” Neuroscience, vol. 113, no. 1, pp. 155–166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. C. M. Serre, D. Farlay, P. D. Delmas, and C. Chenu, “Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers,” Bone, vol. 25, no. 6, pp. 623–629, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. J. M. Jimenez-Andrade, W. G. Mantyh, A. P. Bloom et al., “A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: therapeutic opportunity for treating skeletal pain,” Bone, vol. 46, no. 2, pp. 306–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. J. J. Ivanusic, “Size, neurochemistry, and segmental distribution of sensory neurons innervating the rat tibia,” Journal of Comparative Neurology, vol. 517, no. 3, pp. 276–283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. I. R. Orriss, G. Burnstock, and T. R. Arnett, “Purinergic signalling and bone remodelling,” Current Opinion in Pharmacology, vol. 10, no. 3, pp. 322–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. M. S. Morrison, L. Turin, B. F. King, G. Burnstock, and T. R. Arnett, “ATP is a potent stimulator of the activation and formation of rodent osteoclasts,” Journal of Physiology, vol. 511, no. 2, pp. 495–500, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. B. F. King, L. E. Ziganshina, J. Pintor, and G. Burnstock, “Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH,” British Journal of Pharmacology, vol. 117, no. 7, pp. 1371–1373, 1996. View at Google Scholar · View at Scopus
  63. A. Hoebertz, A. Townsend-Nicholson, R. Glass, G. Burnstock, and T. R. Arnett, “Expression of P2 receptors in bone and cultured bone cells,” Bone, vol. 27, no. 4, pp. 503–510, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. I. Orriss, S. Syberg, N. Wang et al., “Bone phenotypes of P2 receptor knockout mice,” Frontiers in Bioscience, vol. 3, pp. 1038–1046, 2011. View at Google Scholar
  65. A. Hald, R. R. Hansen, M. W. Thomsen et al., “Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790,” International Journal of Cancer, vol. 125, no. 5, pp. 1177–1185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. W. G. Mantyh, J. M. Jimenez-Andrade, J. I. Stake et al., “Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain,” Neuroscience, vol. 171, no. 2, pp. 588–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. T. K. Y. Kaan, P. K. Yip, S. Patel et al., “Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats,” Brain, vol. 133, no. 9, pp. 2549–2564, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. S. González-Rodríguez, M. Pevida, B. P. Roques et al., “Involvement of enkephalins in the inhibition of osteosarcoma-induced thermal hyperalgesia evoked by the blockade of peripheral P2X3 receptors,” Neuroscience Letters, vol. 465, no. 3, pp. 285–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. R. R. Hansen, A. Nasser, S. Falk et al., “Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice,” European Journal of Pharmacology, vol. 688, no. 1–3, pp. 27–34, 2012. View at Google Scholar
  70. J. X. Wu, M. Y. Xu, and X. R. Miao, “Functional up-regulation of P2X3 receptors in dorsal root ganglion in a rat model of bone cancer pain,” European Journal of Pain. In press. View at Publisher · View at Google Scholar
  71. M. S. Ramer, E. J. Bradbury, and S. B. McMahon, “Nerve growth factor induces P2X3 expression in sensory neurons,” Journal of Neurochemistry, vol. 77, no. 3, pp. 864–875, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. M. F. Jarvis, “The neural-glial purinergic receptor ensemble in chronic pain states,” Trends in Neurosciences, vol. 33, no. 1, pp. 48–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. M. F. Jarvis, E. C. Burgard, S. McGaraughty et al., “A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 26, pp. 17179–17184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. S. McGaraughty, P. Honore, C. T. Wismer et al., “Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain,” British Journal of Pharmacology, vol. 146, no. 2, pp. 180–188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. R. R. Ji, R. W. Gereau, M. Malcangio, and G. R. Strichartz, “MAP kinase and pain,” Brain Research Reviews, vol. 60, no. 1, pp. 135–148, 2009. View at Google Scholar
  76. L. N. Naemsch, A. F. Weidema, S. M. Sims, T. M. Underhill, and S. J. Dixon, “P2X4 purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts,” Journal of Cell Science, vol. 112, no. 23, pp. 4425–4435, 1999. View at Google Scholar · View at Scopus
  77. C. J. Woolf and M. W. Salter, “Neuronal plasticity: increasing the gain in pain,” Science, vol. 288, no. 5472, pp. 1765–1768, 2000. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Honore, N. M. Luger, M. A. C. Sabino et al., “Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord,” Nature Medicine, vol. 6, no. 5, pp. 521–528, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Hald, S. Nedergaard, R. R. Hansen, M. Ding, and A. M. Heegaard, “Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain,” European Journal of Pain, vol. 13, no. 2, pp. 138–145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Illes, A. Verkhratsky, G. Burnstock, and H. Franke, “P2X receptors and their roles in astroglia in the central and peripheral nervous system,” The Neuroscientist. In press. View at Publisher · View at Google Scholar
  81. R. D. Fields and G. Burnstock, “Purinergic signalling in neuron-glia interactions,” Nature Reviews Neuroscience, vol. 7, no. 6, pp. 423–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Ulmann, J. P. Hatcher, J. P. Hughes et al., “Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain,” Journal of Neuroscience, vol. 28, no. 44, pp. 11263–11268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Trang, S. Beggs, X. Wan, and M. W. Salter, “P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation,” Journal of Neuroscience, vol. 29, no. 11, pp. 3518–3528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. J. A. M. Coull, S. Beggs, D. Boudreau et al., “BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain,” Nature, vol. 438, no. 7070, pp. 1017–1021, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Ferrari, C. Pizzirani, E. Adinolfi et al., “The P2X7 receptor: a key player in IL-1 processing and release,” Journal of Immunology, vol. 176, no. 7, pp. 3877–3883, 2006. View at Google Scholar · View at Scopus
  86. I. Hide, M. Tanaka, A. Inoue et al., “Extracellular ATP triggers tumor necrosis factor-α release from rat microglia,” Journal of Neurochemistry, vol. 75, no. 3, pp. 965–972, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Suzuki, I. Hide, K. Ido, S. Kohsaka, K. Inoue, and Y. Nakata, “Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia,” Journal of Neuroscience, vol. 24, no. 1, pp. 1–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Inoue, “P2 receptors and chronic pain,” Purinergic Signalling, vol. 3, no. 1-2, pp. 135–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. F. Bianco, E. Pravettoni, A. Colombo et al., “Astrocyte-derived ATP induces vesicle shedding and IL-1β release from microglia,” Journal of Immunology, vol. 174, no. 11, pp. 7268–7277, 2005. View at Google Scholar · View at Scopus
  90. V. Montana, E. B. Malarkey, C. Verderio, M. Matteoli, and V. Parpura, “Vesicular transmitter release from astrocytes,” Glia, vol. 54, no. 7, pp. 700–715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. C. E. Stout, J. L. Costantin, C. C. G. Naus, and A. C. Charles, “Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels,” The Journal of Biological Chemistry, vol. 277, no. 12, pp. 10482–10488, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Li, I. Bjelobaba, Z. Yan, M. Kucka, M. Tomić, and S. S. Stojilkovic, “Expression and roles of pannexins in ATP release in the pituitary gland,” Endocrinology, vol. 152, no. 6, pp. 2342–2352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Duan and J. T. Neary, “P2X7 receptors: properties and relevance to CNS function,” Glia, vol. 54, no. 7, pp. 738–746, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. B. Sung, G. Lim, and J. Mao, “Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats,” Journal of Neuroscience, vol. 23, no. 7, pp. 2899–2910, 2003. View at Google Scholar · View at Scopus
  95. W. Wang, W. Wang, Y. Wang, J. Huang, S. Wu, and Y. Q. Li, “Temporal changes of astrocyte activation and glutamate transporter-1 expression in the spinal cord after spinal nerve ligation-induced neuropathic pain,” Anatomical Record, vol. 291, no. 5, pp. 513–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. W. J. Xin, H. R. Weng, and P. M. Dougherty, “Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation,” Molecular Pain, vol. 5, article 15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. V. L. Tawfik, M. R. Regan, C. Haenggeli et al., “Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection,” Neuroscience, vol. 152, no. 4, pp. 1086–1092, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. Y. P. Liu, C. S. Yang, M. C. Chen, S. H. Sun, and S. F. Tzeng, “Ca2+-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X7 receptor-mediated phosphoinositide 3-kinase signaling,” Journal of Neurochemistry, vol. 113, no. 1, pp. 213–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. J. C. Lo, W. C. Huang, Y. C. Chou, C. H. Tseng, W. L. Lee, and S. H. Sun, “Activation of P2X7 receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms,” Journal of Neurochemistry, vol. 105, no. 1, pp. 151–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. N. Morioka, M. J. Abdin, T. Kitayama, K. Morita, Y. Nakata, and T. Dohi, “P2X7 receptor stimulation in primary cultures of rat spinal microglia induces downregulation of the activity for glutamate transport,” Glia, vol. 56, no. 5, pp. 528–538, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Chaumont and B. S. Khakh, “Patch-clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 33, pp. 12063–12068, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. V. Poornima, M. Madhupriya, S. Kootar, G. Sujatha, A. Kumar, and A. K. Bera, “P2X7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization,” Journal of Molecular Neuroscience, vol. 46, no. 3, pp. 585–594, 2012. View at Google Scholar
  103. P. Pelegrin and A. Surprenant, “Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor,” EMBO Journal, vol. 25, no. 21, pp. 5071–5082, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Locovei, E. Scemes, F. Qiu, D. C. Spray, and G. Dahl, “Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex,” FEBS Letters, vol. 581, no. 3, pp. 483–488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. T. M. Egan, D. S. K. Samways, and Z. Li, “Biophysics of P2X receptors,” Pflugers Archiv European Journal of Physiology, vol. 452, no. 5, pp. 501–512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. P. Pelegrín, “Many ways to dilate the P2X7 receptor pore,” British Journal of Pharmacology, vol. 163, no. 5, pp. 908–911, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. C. Marques-Da-Silva, M. M. Chaves, N. G. Castro, R. Coutinho-Silva, and M. Z. P. Guimaraes, “Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action,” British Journal of Pharmacology, vol. 163, no. 5, pp. 912–926, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. X. J. Xu, M. Boumechache, L. E. Robinson et al., “Splice-variants of the P2X7 receptor reveal differential agonist-dependence and functional coupling with pannexin-1,” Journal of Cell Science. In press.
  109. S. J. Fuller, L. Stokes, K. K. Skarratt, B. J. Gu, and J. S. Wiley, “Genetics of the P2X7 receptor and human disease,” Purinergic Signalling, vol. 5, no. 2, pp. 257–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. C. M. Miller, A. M. Zakrzewski, R. J. Ikin et al., “Dysregulation of the inflammatory response to the parasite, toxoplasma gondii, in P2X7 receptor-deficient mice,” International Journal for Parasitology, vol. 41, no. 3, pp. 301–308, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. R. E. Sorge, T. Trang, R. Dorfman et al., “Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity,” Nature Medicine, vol. 18, no. 4, pp. 595–599, 2012. View at Publisher · View at Google Scholar
  112. I. P. Chessell, J. P. Hatcher, C. Bountra et al., “Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain,” Pain, vol. 114, no. 3, pp. 386–396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. R. R. Hansen, C. K. Nielsen, A. Nasser et al., “P2X7 receptor-deficient mice are susceptible to bone cancer pain,” Pain, vol. 152, no. 8, pp. 1766–1776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Yao, X. Chang, Y. Chu et al., “Antiallodynic effects of propentofylline elicited by interrupting spinal glial function in a rat model of bone cancer pain,” Journal of Neuroscience Research, vol. 89, no. 11, pp. 1877–1886, 2011. View at Publisher · View at Google Scholar · View at Scopus
  115. L. N. Wang, J. P. Yang, and Y. Zhan, “Minocycline-induced reduction of brain-derived neurotrophic factor expression in relation to cancer-induced bone pain in rats,” Journal of Neuroscience Research, vol. 90, no. 3, pp. 672–681, 2012. View at Publisher · View at Google Scholar
  116. A. Nicke, Y. H. Kuan, M. Masin et al., “A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice,” The Journal of Biological Chemistry, vol. 284, no. 38, pp. 25813–25822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. K. Kobayashi, H. Yamanaka, T. Fukuoka, Y. Dai, K. Obata, and K. Noguchi, “P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain,” Journal of Neuroscience, vol. 28, no. 11, pp. 2892–2902, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. H. Tozaki-Saitoh, M. Tsuda, H. Miyata, K. Ueda, S. Kohsaka, and K. Inoue, “P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury,” Journal of Neuroscience, vol. 28, no. 19, pp. 4949–4956, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. H. S. Xiao, Q. H. Huang, F. X. Zhang et al., “Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 12, pp. 8360–8365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. J. Chen, L. Wang, Y. ZhangYang J., and J. Yang, “P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain,” Acta Biochimica et Biophysica Sinica, vol. 44, no. 4, pp. 367–372, 2012. View at Publisher · View at Google Scholar
  121. G. Burnstock, “Physiology and pathophysiology of purinergic neurotransmission,” Physiological Reviews, vol. 87, no. 2, pp. 659–797, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. Z. Gerevich, C. Müller, and P. Illes, “Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons,” European Journal of Pharmacology, vol. 521, no. 1–3, pp. 34–38, 2005. View at Publisher · View at Google Scholar · View at Scopus